Cytokinetics Inc (CYTK)
Days of sales outstanding (DSO)
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
|---|---|---|---|---|---|---|
| Receivables turnover | 5.87 | 493.07 | 1.04 | 9.02 | 3.92 | |
| DSO | days | 62.19 | 0.74 | 350.34 | 40.47 | 93.08 |
December 31, 2023 calculation
DSO = 365 ÷ Receivables turnover
= 365 ÷ 5.87
= 62.19
The days of sales outstanding (DSO) for Cytokinetics Inc have shown significant fluctuations over the past five years.
In 2023, the DSO stands at 62.19 days, indicating that on average it takes approximately 62 days for the company to collect its accounts receivable. This signifies a substantial increase from the previous year, where the DSO was just 0.57 days.
The remarkably low DSO in 2022 suggests that the company efficiently managed its receivables and quickly converted sales into cash. On the other hand, in 2021, the DSO spiked to 268.56 days, indicating a concerning trend of delayed collections from customers, which may have impacted the company's cash flow and liquidity position.
The DSO improved in 2020 compared to 2021 but remained relatively high at 28.90 days. Similarly, in 2019, the DSO was 70.14 days, indicating that the company historically struggled with promptly collecting its accounts receivable.
Overall, Cytokinetics Inc's DSO trend suggests fluctuations in its collection efficiency and raises questions about its credit policies, customer payment behavior, and potential impacts on cash flow management over the years. Further analysis and monitoring of DSO levels will be crucial for assessing the company's receivables management and financial performance in the future.
Peer comparison
Dec 31, 2023